PharmaVOICE - 
April 2021
Purchase Issue
In Every Issue
Letter from the Editor
Password protected? How secure is your healthcare and other online [...]
By

Taren Grom, Editor

Upfront
Astellas Oncology Fifth Annual C3 Prize Winners Astellas Oncology has [...]
By

PharmaVOICE Staff

HealthTech
Robots Measure Vitals to Minimize Interactions with COVID Patients Trend [...]
By

PharmaVOICE Staff

Artificial Intelligence
Iktos Partners with Pfizer for AI-based Drug Design Project Trend [...]
By

PharmaVOICE Staff

On The Cover

Data Privacy: A Delicate Balance
New digital health technologies and increased awareness about public health due to the COVID-19 pandemic are paving the way for a fundamental shift in healthcare data privacy. The recent advent of new, portable digital health technologies and the increasing involvement of tech giants such as Google and Facebook in mining healthcare data have brought the [...]
By

PharmaVOICE Staff

Features

Virtual Launches
Industry thought leaders discuss what they learned during their recent pivot to virtual launches. Launching a product in the past year, during a global pandemic, required a nimbleness that often belies a pharma product launch, but several companies accepted the challenge and created new strategies that enabled them to pivot and launch successfully under the [...]
By

Robin Robinson

Women of Influence
“I realized that if I was willing to step up and be in the spotlight, I’d be able to make everyone else around me much more powerful as well.” – Alaina Percival, CEO, Women Who Code Welcome to our second annual Woman of Influence feature. We are excited to continue our coverage of the women [...]
By

Taren Grom, Editor

SHOWCASE: Precision Medicine: Expanding the Frontiers of Precision Medicine
The Human Genome Project changed the face of modern medicine. As knowledge has grown about genomics and the gene mutations that cause disease, it has become more and more apparent that the traditional one-size-fits-all approach to medicine doesn’t work. Reports suggest that in many disease areas, the percentage of patients who don’t benefit from a [...]
By

PharmaVOICE Staff

Six Cell and Gene Therapy Commercialization Trends
What to Watch in the Next 12 Months and Beyond 2020 was a noteworthy year for cell and gene therapies (CGT), which conservatively account for 12% of the pharma industry’s clinical pipeline and 16% of its preclinical pipeline. Despite unprecedented global challenges caused by COVID-19, the CGT market attracted a record-breaking .9 billion in capital [...]
By

Amy DuRoss, CEO and Co-founder, Vineti and Keith Martino, VP/General Manager, Biopharma Services, Cardinal Health Specialty Solutions

Precision Medicine and Predictive Action Drive Measurable Impact for Patients
The Institute for Precision Medicine defines “Precision Medicine” as the “medical approach that proposes to prevent and treat disease based upon a person’s unique genetic makeup and their lifestyle habits. Precision medicine, the ability to accurately measure specific predictors of patient outcomes is implemented in personalized clinical care.” Thanks to recent advancements in bioinformatics, big [...]
By

Maria Kirsch, Senior VP & Head of Patient Services, EVERSANA

Commanders & Chiefs: Chief Digital Officers
Some say the chief digital officer (CDO) is a “futurist” who predicts trends based on current market conditions and then works to ensure that the business moves to react to those conditions. Others consider the CDO to be that executive who brings together various disciplines within an enterprise to reinvent the business, thereby creating a [...]
By

PharmaVOICE Staff

Trend Tracking
The industry is moving fast, and we asked our community of PharmaVOICE 100 inspired leaders to weigh in on their top priorities for the remainder of 2021 as they prepare for the next normal as well as the leadership skills that got them through the pandemic. Tammy Guld Global Head Multi-TA Project Management, Research & [...]
By

PharmaVOICE Staff

FEEDBACK